← Back to headlines
Immunic CEO Discusses Q2 Progress and Phase 3 MS Trial Milestones
The CEO of Immunic provided an update on the company's progress in the second quarter and highlighted key milestones achieved in its Phase 3 multiple sclerosis trial.
10 Aug, 19:07 — 10 Aug, 19:07
Sources
Showing 1 of 1 sources
